Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01690494 · ClinicalTrials.gov registry record · NA
Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders
A NA study of Substance-Related Disorders and Sexually Transmitted Diseases, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT01690494: Completed NA study of Substance-Related Disorders and Sexually Transmitted Diseases, sponsored by Columbia University.
NCT01690494 is a NA study of Substance-Related Disorders and Sexually Transmitted Diseases that has completed, run by Columbia University. The registered enrollment target is 480 participants, below the 1,513-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01690494, a NA study of Substance-Related Disorders and Sexually Transmitted Diseases, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated human immunodeficiency virus (HIV) and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or probation (CCP) sites in NYC, compared to CCP standard treatment of care services (TAU). The primary outcomes are to reduce sexually transmitted infections (STIs) and increase condom use.
Conditions Studied
Interventions
- BEHAVIORAL TAU
- BEHAVIORAL PACT
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2013-06-11 |
| Est. Completion | 2017-09-30 |
| Phase | NA |
What the finished NCT01690494 record still lists
NCT01690494 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 1,513-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (68% lower).
The record links to 3 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which TAU is the first listed.
NCT01690494 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01690494 about?
NCT01690494 is a clinical study titled "Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders". This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated human immunodeficiency virus (HIV) and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with ...
What is the current status of trial NCT01690494?
This trial is currently completed. It is a NA study. The enrollment target is 480 participants. The study started on 2013-06-11. Estimated completion is 2017-09-30.
What conditions does trial NCT01690494 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Sexually Transmitted Diseases, Unsafe Sex.
What interventions are being tested in trial NCT01690494?
The interventions under investigation include: TAU (BEHAVIORAL), PACT (BEHAVIORAL).
Who is sponsoring clinical trial NCT01690494?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01690494 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01690494's enrollment target sits among peer trials
480 9th of 58 higher than 50 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI